Bladder Cancer

Latest News

Shilpa Gupta, MD, discusses bladder preserving strategies for unfit or young patients, trials assessing immunotherapy combinations, and results from the BLASST-1 trial presented at ASCO GU.

Expert Examines Current and Future Strategies for Bladder Cancer Subtype

March 13th 2023

Shilpa Gupta, MD, discusses bladder preserving strategies for unfit or young patients, trials assessing immunotherapy combinations, and results from the BLASST-1 trial presented at ASCO GU.

First-Line Avelumab Comparable With SOC for Bladder Cancer Subtype

By Ryan Scott

February 20th 2023

A retrospective study clarifies how the implementation of avelumab maintenance looks in real-world practice, according to an expert from Seattle Cancer Care Alliance.

First-line maintenance with avelumab in locally advanced or metastatic urothelial carcinoma yields efficacy that appears consistent between clinical and real-world settings.

Frontline Maintenance Avelumab Yields Consistent Efficacy in Urothelial Carcinoma

By Lindsay Fischer

February 20th 2023

First-line maintenance with avelumab in locally advanced or metastatic urothelial carcinoma yields efficacy that appears consistent between clinical and real-world settings.

Atezolizumab/Chemo Demonstrates Survival Trend in Urothelial Carcinoma

By Ashling Wahner

February 18th 2023

Results from the phase 3 IMvigor130 trial reveal a trend towards overall survival improvement when atezolizumab plus chemotherapy was given to patients with locally advanced or metastatic urothelial carcinoma vs placebo.

Single Agent Atezolizumab Does Not Improve Survival in Urothelial Cancer

By Caroline Seymour

February 18th 2023

An exploratory analysis indicates that overall survival did not improve with the use of single-agent atezolizumab in untreated locally advanced or metastatic urothelial cancer.

...

10 11 12 13 14

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777